US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Neumora Therapeutics, Inc.

0.7569

-0.0425-5.32%

Post-market: 0.76020.0033+0.44%19:46 EDT

Volume:10.85M

Turnover:8.24M

Market Cap:122.43M

PE:-0.47

High:0.8174

Open:0.7911

Low:0.7569

Close:0.7994

Loading ...

Overview Company News Filings

Neumora Therapeutics downgraded to Underperform from Buy at BofA

William Blair Downgrades Neumora Therapeutics to Market Perform From Outperform

MT Newswires Live

Neumora Therapeutics downgraded to Market Perform from Outperform at William Blair

William Blair downgrades Neumora Therapeutics, Inc. (NMRA) to a Hold

BUZZ-U.S. STOCKS ON THE MOVE-Mobileye, Visionary Holdings, Wolfspeed

JNJ Halts Development of Depression Drug Over Efficacy Concerns

Neumora Therapeutics Shares Fall 13.8% After Johnson & Johnson Stops Studies of Rival Depression Drug

THOMSON REUTERS

BUZZ-Neumora falls as J&J's setback triggers concerns over depression drug

Johnson & Johnson Stops Late-Stage Depression Study Over 'Insufficient Efficacy'

Neumora Therapeutics Shares Down 11.2% Premarket After Johnson & Johnson Stops Studies of Rival Depression Drug

THOMSON REUTERS

Neumora Therapeutics downgraded to Neutral from Buy at Guggenheim

BUZZ-Neumora's IPO bookrunner Stifel cuts to 'hold' after J&J setback

Stifel Downgrades Neumora Therapeutics to Hold From Buy, Adjusts Price Target to $2 From $6

MT Newswires Live

Neumora Therapeutics Inc : Stifel Cuts to Hold From Buy; Cuts Target Price to $2 From $6

THOMSON REUTERS

Neumora Therapeutics to Present at Leerink Global Healthcare Conference

Strategic Adjustments and MDD Focus Drive Buy Rating for Neumora Therapeutics Amid Study Delays

Neumora Therapeutics Price Target Maintained With a $5.00/Share by Needham

RBC Capital Sticks to Its Hold Rating for Neumora Therapeutics, Inc. (NMRA)

Neumora Therapeutics price target lowered to $18 from $30 at H.C. Wainwright

Neumora Therapeutics Earnings Call: Balancing Growth and Challenges

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NMRA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NMRA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NMRA\",,,,,undefined,":{"symbol":"NMRA","market":"US","secType":"STK","nameCN":"Neumora Therapeutics, Inc.","latestPrice":0.7569,"timestamp":1751054400000,"preClose":0.7994,"halted":0,"volume":10854038,"hourTrading":{"tag":"盘后","latestPrice":0.7602,"preClose":0.7569,"latestTime":"19:46 EDT","volume":3355195,"amount":2540536.976486,"timestamp":1751067986090},"delay":0,"floatShares":85865485,"shares":161747922,"eps":-1.610306,"marketStatus":"Market Closed","change":-0.0425,"latestTime":"06-27 16:00:00 EDT","open":0.7911,"high":0.8174,"low":0.7569,"amount":8242902.701012201,"amplitude":0.075682,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.610306,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1751270400000},"marketStatusCode":7,"adr":0,"listingDate":1694750400000,"exchange":"NASDAQ","adjPreClose":0.7994,"preHourTrading":{"tag":"盘前","latestPrice":0.8001,"preClose":0.7994,"latestTime":"09:21 EDT","volume":106,"amount":87.9336038,"timestamp":1751030514999},"postHourTrading":{"tag":"盘后","latestPrice":0.7602,"preClose":0.7569,"latestTime":"19:46 EDT","volume":3355195,"amount":2540536.976486,"timestamp":1751067986090},"volumeRatio":16.693809193630077,"impliedVol":3.0628,"impliedVolPercentile":0.824},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NMRA\",,,,,undefined,":{"symbol":"NMRA","floatShares":85865485,"roa":"-48.50%","roe":"-79.05%","lyrEps":-1.529624,"volumeRatio":16.693809193630077,"shares":161747922,"dividePrice":0,"high":0.8174,"amplitude":0.075682,"preClose":0.7994,"low":0.7569,"week52Low":0.611,"pbRate":"0.54","week52High":17.1874,"institutionHeld":0,"latestPrice":0.7569,"eps":-1.610306,"divideRate":0,"volume":10854038,"delay":0,"ttmEps":-1.610306,"open":0.7911,"prevYearClose":10.6,"prevWeekClose":0.7857,"prevMonthClose":0.7163,"prevQuarterClose":1,"fiveDayClose":0.7857,"twentyDayClose":0.7187,"sixtyDayClose":0.9133},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NMRA\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524108456","title":"Neumora Therapeutics downgraded to Underperform from Buy at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2524108456","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524108456?lang=en_us&edition=fundamental","pubTime":"2025-04-02 16:55","pubTimestamp":1743584128,"startTime":"0","endTime":"0","summary":"BofA double downgraded Neumora Therapeutics (NMRA) to Underperform from Buy with a price target of $1, down from $7. The firm is taking a more cons...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neumora-therapeutics-downgraded-to-underperform-from-buy-at-bofa?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neumora-therapeutics-downgraded-to-underperform-from-buy-at-bofa?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NMRA","LENZ"],"gpt_icon":0},{"id":"2518733247","title":"William Blair Downgrades Neumora Therapeutics to Market Perform From Outperform","url":"https://stock-news.laohu8.com/highlight/detail?id=2518733247","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518733247?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:37","pubTimestamp":1741606627,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics (NMRA) has an average rating of overweight and mean price target of $6.67, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fro","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","NMRA"],"gpt_icon":0},{"id":"2517746163","title":"Neumora Therapeutics downgraded to Market Perform from Outperform at William Blair","url":"https://stock-news.laohu8.com/highlight/detail?id=2517746163","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517746163?lang=en_us&edition=fundamental","pubTime":"2025-03-08 06:06","pubTimestamp":1741385178,"startTime":"0","endTime":"0","summary":"William Blair downgraded Neumora Therapeutics (NMRA) to Market Perform from Outperform. Published first on TheFly – the ultimate source for real-ti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neumora-therapeutics-downgraded-to-market-perform-from-outperform-at-william-blair?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neumora-therapeutics-downgraded-to-market-perform-from-outperform-at-william-blair?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NMRA","LENZ"],"gpt_icon":0},{"id":"2517469605","title":"William Blair downgrades Neumora Therapeutics, Inc. (NMRA) to a Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2517469605","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517469605?lang=en_us&edition=fundamental","pubTime":"2025-03-08 05:26","pubTimestamp":1741382778,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics, Inc. (NMRA – Research Report) received a Hold rating and price target from William Blair analyst Myles Minter today. Accordin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/william-blair-downgrades-neumora-therapeutics-inc-nmra-to-a-hold?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/william-blair-downgrades-neumora-therapeutics-inc-nmra-to-a-hold?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NMRA"],"gpt_icon":0},{"id":"2517454561","title":"BUZZ-U.S. STOCKS ON THE MOVE-Mobileye, Visionary Holdings, Wolfspeed","url":"https://stock-news.laohu8.com/highlight/detail?id=2517454561","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517454561?lang=en_us&edition=fundamental","pubTime":"2025-03-08 02:52","pubTimestamp":1741373564,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Mobileye, Visionary Holdings, WolfspeedEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsle","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nL3N3PQ1AL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBLY","BK4559","F","GM","IOT","SG9999015945.SGD","BHVN","HPE","MLNK","ODFL","KLXE","W","WBA","LU0368265764.SGD","HAL","CRMD","BK4534","BK4138","CVX","LU0006061336.USD","LU0708994859.HKD","LU0170899867.USD","NMRA","LU1883839398.USD","NFE","AFBI","WMB","GAP","JAZZ","VEL","LU2361044865.SGD","IE00BMCWC346.EUR","PBPB","LE","LU0068578508.USD","BK4512","LU2471134523.USD","JBHT","LU2552382132.HKD","NEM","WOLF","COO","LU1732800096.USD","CHRW","XOM","COOK"],"gpt_icon":1},{"id":"2517538457","title":"JNJ Halts Development of Depression Drug Over Efficacy Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2517538457","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517538457?lang=en_us&edition=fundamental","pubTime":"2025-03-08 01:45","pubTimestamp":1741369500,"startTime":"0","endTime":"0","summary":"Johnson & Johnson JNJ decided to discontinue the Phase 3 VENTURA development program, which is evaluating aticaprant as an adjunctive treatment for major depressive disorder .Though data from the VENTURA program did confirm that the J&J drug was safe and well-tolerated in study participants, the decision to stop developing it for MDD indication is due to ‘insufficient efficacy in the target patient population.’ However, the pharma giant still intends to explore aticaprant’s potential ‘in other areas of high unmet need.’。J&J is currently undergoing full analyses of data from the VENTURA program and intends to share the same at a future medical meeting.This comes as a setback to J&J, which had high expectations for aticaprant in the MDD indication. The company has forecasted generating annual peak sales in the range of $1-$5 billion from the drug in the now-abandoned indication.J&J Reiterates Long-Term View for Innovative Medicine Biz","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/jnj-halts-development-depression-drug-174500525.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1261432733.SGD","LU1066051498.USD","IE00BFTCPJ56.SGD","LU2602419157.SGD","BK4533","LU1059921491.USD","IE00BDGV0183.EUR","LU0795875086.SGD","IE00B1BXHZ80.USD","IE00BJT1NW94.SGD","LU0098860793.USD","LU1061106388.HKD","LU1674673691.USD","LU1057294990.SGD","JNJ","BK4532","IE00B2B36J28.USD","LU0889566641.SGD","LU1267930813.SGD","LU2129689514.USD","BK4581","IE00B19Z3B42.SGD","ITCI","LU0912757837.SGD","LU2430703178.SGD","NMRA","LU0792757196.USD","LU1066051225.USD","IE00BJJMRZ35.SGD","LU0345769631.USD","LU1732799900.SGD","LU2505996681.GBP","LU0058720904.USD","LU0234572021.USD","LU1732800096.USD","ABVC","IE00B19Z3581.USD","IE0002141913.USD","IE00BSNM7G36.USD","IE0002270589.USD","LU2468319806.SGD","SG9999002224.SGD","SG9999001440.SGD","LU0122379950.USD","LU0234570918.USD","LU0289739699.SGD","LU2112291526.USD","IE00BVYPNV92.GBP","IE00BGHQF631.EUR","IE000M9KFDE8.USD"],"gpt_icon":0},{"id":"2517439580","title":"Neumora Therapeutics Shares Fall 13.8% After Johnson & Johnson Stops Studies of Rival Depression Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2517439580","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517439580?lang=en_us&edition=fundamental","pubTime":"2025-03-07 22:30","pubTimestamp":1741357858,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nFWN3PQ0GA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4534","LU0795875086.SGD","LU1057294990.SGD","LU1894683348.USD","LU1280957306.USD","LU0345770993.USD","LU1267930813.SGD","LU0320765646.SGD","LU0912757837.SGD","LU1935042991.SGD","LU2129689431.USD","LU1430594728.SGD","LU1506573853.SGD","LU1732800096.USD","LU1244550494.USD","BK4568","IE00BVYPNV92.GBP","LU2089984988.USD","LU0882574055.USD","LU2505996509.AUD","BK4532","LU0122379950.USD","LU1066051811.HKD","LU0114720955.EUR","IE0002270589.USD","BK4504","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","LU1244550577.SGD","IE00B4R5TH58.HKD","LU1059921491.USD","LU2430703095.HKD","LU1718418525.SGD","LU2129689514.USD","LU2468319806.SGD","LU1032466523.USD","IE00B1BXHZ80.USD","LU0795875169.SGD","NMRA","SG9999002232.USD","JNJ","LU0345769631.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","LU1066053197.SGD","IE00B3PB1722.GBP","SG9999002224.SGD","IE0002141913.USD","LU1221951129.SGD","BK4559"],"gpt_icon":0},{"id":"2517743572","title":"BUZZ-Neumora falls as J&J's setback triggers concerns over depression drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2517743572","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517743572?lang=en_us&edition=fundamental","pubTime":"2025-03-07 22:11","pubTimestamp":1741356694,"startTime":"0","endTime":"0","summary":"BUZZ-Neumora falls as J&J's setback triggers concerns over depression drug Updates** Shares of Neumora Therapeutics NMRA.O fall 11.2% to $1.35 premarket, set to break three-day winning streak","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nL3N3PQ17A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU1261432733.SGD","LU2430703095.HKD","LU0122379950.USD","BK4588","LU1732800096.USD","LU2112291526.USD","IE00B3PB1722.GBP","LU2430703178.SGD","LU1674673428.USD","BK4592","LU0345769128.USD","LU1221951046.USD","LU1244550221.USD","LU2430703251.USD","BK4533","LU1057294990.SGD","LU0114720955.EUR","LU0203345920.USD","IE00BJJMRZ35.SGD","SF","LU1066051498.USD","LU1585245621.USD","BK4504","BK4127","NMRA","LU1506573853.SGD","LU1066053197.SGD","LU0234570918.USD","LU1430594728.SGD","LU0795875086.SGD","BK4550","IE00B42XCP33.USD","IE00BVYPNV92.GBP","IE0009355771.USD","LU0058720904.USD","LU1032466523.USD","LU1061106388.HKD","LU0203347892.USD","LU1894683348.USD","LU2505996509.AUD","JNJ","LU1162221912.USD","BK4585","LU1244550494.USD","LU0098860793.USD","BK4532","LU0640476718.USD","LU1732799900.SGD","BK4534"],"gpt_icon":0},{"id":"2517243109","title":"Johnson & Johnson Stops Late-Stage Depression Study Over 'Insufficient Efficacy'","url":"https://stock-news.laohu8.com/highlight/detail?id=2517243109","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517243109?lang=en_us&edition=fundamental","pubTime":"2025-03-07 22:03","pubTimestamp":1741356230,"startTime":"0","endTime":"0","summary":"On Friday, Johnson & Johnson  decided to discontinue the Phase 3 VENTURA development program evaluating aticaprant, a kappa opioid receptor  antagonist, as an adjunctive treatment for major depressive disorder .The move follows insufficient efficacy in the target patient population. The data confirmed aticaprant is safe and well-tolerated, and no new safety signals were identified.In January, Neumora Therapeutics, Inc.’s released data from the Phase 3 KOASTAL-1 Study of navacaprant for major depressive disorder.The study did not demonstrate a statistically significant improvement on the primary endpoint of change from baseline in the Montgomery-sberg Depression Rating Scale  total score at Week 6 or the key secondary endpoint of a change from baseline in the Snaith-Hamilton Pleasure Scale  scale.Navacaprant, like aticaprant, is a kappa opioid receptor antagonist. Johnson & Johnsonsays it continues to build on its leadership in Neuroscience.In January, the healthcare giant agreed to acq","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/johnson-johnson-stops-stage-depression-140350234.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SG9999002232.USD","LU2592432038.USD","LU0345769128.USD","NMRA","LU0012050646.USD","LU1778281490.HKD","IE00BVYPNW00.USD","LU2347655156.SGD","BK4588","LU0882574055.USD","JNJ","LU0234570918.USD","LU2089984988.USD","IE00BDGV0183.EUR","LU1066053197.SGD","IE00B4R5TH58.HKD","IE0002270589.USD","ITCI","LU1059921491.USD","LU1032955483.USD","LU0203347892.USD","BK4534","IE0002141913.USD","LU0795875086.SGD","IE000M9KFDE8.USD","LU0109394709.USD","LU2129689514.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU1585245621.USD","SSI","BK4504","IE0034235303.USD","LU1023059063.AUD","LU0203345920.USD","LU1674673428.USD","BK4007","IE00B7SZLL34.SGD","LU2129689431.USD","LU0640476718.USD","SG9999001440.SGD","LU1057294990.SGD","LU0114720955.EUR","LU2505996509.AUD","LU2129689605.HKD","LU1221951129.SGD","BK4568","LU0889566641.SGD","LU0058720904.USD","LU1244550221.USD"],"gpt_icon":0},{"id":"2517433745","title":"Neumora Therapeutics Shares Down 11.2% Premarket After Johnson & Johnson Stops Studies of Rival Depression Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2517433745","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517433745?lang=en_us&edition=fundamental","pubTime":"2025-03-07 21:58","pubTimestamp":1741355935,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nFWN3PQ0G2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999002232.USD","LU0345770993.USD","BK4550","IE00B19Z3B42.SGD","LU0792757196.USD","LU1506573853.SGD","LU1732799900.SGD","LU1894683264.USD","LU2112291526.USD","LU0345770308.USD","LU0466842654.USD","NMRA","IE00BVYPNW00.USD","IE00B3PB1722.GBP","LU0882574055.USD","JNJ","BK4559","LU1066053197.SGD","IE00B4R5TH58.HKD","LU0345769631.USD","LU1196500208.SGD","IE0002270589.USD","LU0289739699.SGD","LU0203347892.USD","IE00B2B36J28.USD","IE00B1BXHZ80.USD","LU1914381329.SGD","LU1061106388.HKD","IE00BFTCPJ56.SGD","LU1929549753.HKD","LU1585245621.USD","LU1023059063.AUD","LU0203345920.USD","SG9999002224.SGD","BK4007","IE00B7SZLL34.SGD","LU2129689431.USD","SG9999001440.SGD","LU1162221912.USD","LU1280957306.USD","LU1066051225.USD","LU0114720955.EUR","IE00B42XCP33.USD","LU1074936037.SGD","LU1032466523.USD","LU1244550494.USD","IE00BSNM7G36.USD","BK4568","LU0058720904.USD","LU1244550221.USD"],"gpt_icon":0},{"id":"2517480075","title":"Neumora Therapeutics downgraded to Neutral from Buy at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2517480075","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517480075?lang=en_us&edition=fundamental","pubTime":"2025-03-07 21:01","pubTimestamp":1741352518,"startTime":"0","endTime":"0","summary":"Guggenheim downgraded Neumora Therapeutics (NMRA) to Neutral from Buy. with no price target following yesterday’s announcement that Johnson & Johns...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neumora-therapeutics-downgraded-to-neutral-from-buy-at-guggenheim?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neumora-therapeutics-downgraded-to-neutral-from-buy-at-guggenheim?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","NMRA"],"gpt_icon":0},{"id":"2517648768","title":"BUZZ-Neumora's IPO bookrunner Stifel cuts to 'hold' after J&J setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2517648768","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517648768?lang=en_us&edition=fundamental","pubTime":"2025-03-07 20:55","pubTimestamp":1741352129,"startTime":"0","endTime":"0","summary":"BUZZ-Neumora's IPO bookrunner Stifel cuts to 'hold' after J&J setback ** Brokerage Stifel cuts rating on Neumora Therapeutics NMRA.O to \"hold\" from \"buy\" after Johnson & Johnson JNJ.N scrapped trials ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nL3N3PQ11Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0466842654.USD","IE0002270589.USD","LU1023059063.AUD","LU0320765646.SGD","LU1914381329.SGD","NMRA","LU0889566641.SGD","LU1674673428.USD","BK4592","LU1244550577.SGD","BK4550","LU2505996681.GBP","LU1430594728.SGD","LU0289739699.SGD","LU1032466523.USD","LU1066053197.SGD","IE00B19Z3B42.SGD","LU0122379950.USD","LU1280957306.USD","LU0792757196.USD","IE00BVYPNV92.GBP","LU0098860793.USD","LU1267930813.SGD","LU1929549753.HKD","IE0002141913.USD","IE0009355771.USD","IE00BGHQF631.EUR","LU1732799900.SGD","LU0882574055.USD","LU2430703251.USD","JNJ","IE00B2B36J28.USD","BK4588","LU1221951129.SGD","IE00B42XCP33.USD","LU2592432038.USD","BK4007","LU0345770308.USD","IE00B19Z3581.USD","LU0203345920.USD","LU1244550221.USD","SG9999002224.SGD","LU0234572021.USD","LU1061106388.HKD","IE00B3PB1722.GBP","LU1674673691.USD","LU2505996509.AUD","IE0034235303.USD","LU1778281490.HKD","LU1261432733.SGD"],"gpt_icon":0},{"id":"2517484901","title":"Stifel Downgrades Neumora Therapeutics to Hold From Buy, Adjusts Price Target to $2 From $6","url":"https://stock-news.laohu8.com/highlight/detail?id=2517484901","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517484901?lang=en_us&edition=fundamental","pubTime":"2025-03-07 20:26","pubTimestamp":1741350386,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics (NMRA) has an average rating of overweight and mean price target of $6.71, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fro","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NMRA","SF","LENZ"],"gpt_icon":0},{"id":"2517548196","title":"Neumora Therapeutics Inc : Stifel Cuts to Hold From Buy; Cuts Target Price to $2 From $6","url":"https://stock-news.laohu8.com/highlight/detail?id=2517548196","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517548196?lang=en_us&edition=fundamental","pubTime":"2025-03-07 20:08","pubTimestamp":1741349287,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nFWN3PQ10I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","NMRA"],"gpt_icon":0},{"id":"2516679796","title":"Neumora Therapeutics to Present at Leerink Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2516679796","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516679796?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:30","pubTimestamp":1741095000,"startTime":"0","endTime":"0","summary":"WATERTOWN, Mass., March 04, 2025  -- Neumora Therapeutics, Inc. , a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven clinical and pre-clinical brain disease programs, today announced that the Company will present at the Leerink Global Healthcare Conference being held in Miami, FL on Tuesday, March 11, 2025 at 10:00 a.m. ET.About NeumoraNeumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. Our therapeutic pipeline currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Our work is supported by an integrated suite of translational, clinical, and computational tools to generate insights that can enable precision medicine approaches.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neumora-therapeutics-present-leerink-global-133000540.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NMRA","LENZ","BK4137","HCSG","BK4139","BK4007"],"gpt_icon":0},{"id":"2516675847","title":"Strategic Adjustments and MDD Focus Drive Buy Rating for Neumora Therapeutics Amid Study Delays","url":"https://stock-news.laohu8.com/highlight/detail?id=2516675847","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516675847?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:35","pubTimestamp":1741091742,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics, Inc. (NMRA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ami Fadia...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/strategic-adjustments-and-mdd-focus-drive-buy-rating-for-neumora-therapeutics-amid-study-delays?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/strategic-adjustments-and-mdd-focus-drive-buy-rating-for-neumora-therapeutics-amid-study-delays?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NMRA","LENZ","ABVC"],"gpt_icon":0},{"id":"2516967687","title":"Neumora Therapeutics Price Target Maintained With a $5.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2516967687","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516967687?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:34","pubTimestamp":1741091640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NMRA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 04, 2025 07:34 ET (12:34 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","NMRA"],"gpt_icon":0},{"id":"2516788956","title":"RBC Capital Sticks to Its Hold Rating for Neumora Therapeutics, Inc. (NMRA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2516788956","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516788956?lang=en_us&edition=fundamental","pubTime":"2025-03-04 19:50","pubTimestamp":1741089004,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Brian Abrahams from RBC Capital maintained a Hold rating on Neumora Therapeutics, Inc. (NMRA – Research Report), wi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-its-hold-rating-for-neumora-therapeutics-inc-nmra?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-its-hold-rating-for-neumora-therapeutics-inc-nmra?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NMRA"],"gpt_icon":0},{"id":"2516220866","title":"Neumora Therapeutics price target lowered to $18 from $30 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2516220866","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516220866?lang=en_us&edition=fundamental","pubTime":"2025-03-04 19:11","pubTimestamp":1741086704,"startTime":"0","endTime":"0","summary":"H.C. Wainwright lowered the firm’s price target on Neumora Therapeutics (NMRA) to $18 from $30 and keeps a Buy rating on the shares. The firm says ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neumora-therapeutics-price-target-lowered-to-18-from-30-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neumora-therapeutics-price-target-lowered-to-18-from-30-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NMRA","LENZ"],"gpt_icon":0},{"id":"2516966306","title":"Neumora Therapeutics Earnings Call: Balancing Growth and Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2516966306","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516966306?lang=en_us&edition=fundamental","pubTime":"2025-03-04 08:47","pubTimestamp":1741049278,"startTime":"0","endTime":"0","summary":"Neumora Therapeutics, Inc. (($NMRA)) has held its Q4 earnings call. Read on for the main highlights of the call. Neumora Therapeutics, Inc. recentl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neumora-therapeutics-earnings-call-balancing-growth-and-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neumora-therapeutics-earnings-call-balancing-growth-and-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","NMRA"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":2,"totalSize":111,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NMRA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-12","symbol":"NMRA","fiscalQuarterEnding":"2025/03","expectedEps":-0.4,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"post","actualEps":-0.42},{"market":"US","date":"2024-11-12","symbol":"NMRA","fiscalQuarterEnding":"2024/09","expectedEps":-0.38,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NMRA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NMRA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.375,"hold":0.625,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.625,"analysts":8,"updateTime":1743566400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NMRA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NMRA","date":"2025-06-26","current":-0.506383,"percent":0.899522,"low":-19.620035,"twenty":-11.900512,"median":-6.56038,"eighty":-0.940658,"high":-0.385538,"avg":-7.178608,"sd":5.247267,"marketCap":130676146},"quantilePoints":[{"date":"2023-09-15","current":-19.620035,"twenty":-19.620035,"median":-19.620035,"eighty":-19.620035,"marketCap":2583134632},{"date":"2023-09-22","current":-12.753675,"twenty":-18.754446,"median":-15.453663,"eighty":-12.753675,"marketCap":1679123396},{"date":"2023-09-28","current":-13.691957,"twenty":-17.415667,"median":-13.628246,"eighty":-12.772209,"marketCap":1802655635},{"date":"2023-10-05","current":-13.813351,"twenty":-16.65135,"median":-13.723658,"eighty":-12.773914,"marketCap":1818638110},{"date":"2023-10-13","current":-11.180579,"twenty":-14.994038,"median":-13.691957,"eighty":-12.763183,"marketCap":1472012710},{"date":"2023-10-20","current":-11.493728,"twenty":-13.94093,"median":-13.080265,"eighty":-11.639864,"marketCap":1513241282},{"date":"2023-10-27","current":-14.254079,"twenty":-14.080107,"median":-13.080265,"eighty":-11.690896,"marketCap":1876663508},{"date":"2023-11-03","current":-10.734234,"twenty":-13.848145,"median":-12.776843,"eighty":-11.493728,"marketCap":1667466680},{"date":"2023-11-10","current":-10.420012,"twenty":-13.826354,"median":-12.7442,"eighty":-11.403032,"marketCap":1618655149},{"date":"2023-11-17","current":-11.79624,"twenty":-13.813351,"median":-12.154821,"eighty":-11.403032,"marketCap":1832439792},{"date":"2023-11-24","current":-11.717599,"twenty":-13.766958,"median":-11.806071,"eighty":-11.438475,"marketCap":1820223526},{"date":"2023-12-01","current":-12.041995,"twenty":-13.704638,"median":-11.815901,"eighty":-11.48267,"marketCap":1870615621},{"date":"2023-12-08","current":-12.26809,"twenty":-13.59002,"median":-11.825731,"eighty":-11.493283,"marketCap":1905737383},{"date":"2023-12-15","current":-14.381583,"twenty":-13.717318,"median":-11.894542,"eighty":-11.493728,"marketCap":2234049513},{"date":"2023-12-22","current":-13.75245,"twenty":-13.821153,"median":-12.041995,"eighty":-11.521564,"marketCap":2136319390},{"date":"2023-12-29","current":-16.848963,"twenty":-14.008036,"median":-12.137729,"eighty":-11.563317,"marketCap":2617334836},{"date":"2024-01-05","current":-16.111698,"twenty":-14.24211,"median":-12.26809,"eighty":-11.573312,"marketCap":2502807349},{"date":"2024-01-12","current":-14.991056,"twenty":-14.660761,"median":-12.728927,"eighty":-11.585874,"marketCap":2328725569},{"date":"2024-01-19","current":-14.411074,"twenty":-14.428768,"median":-12.751722,"eighty":-11.613398,"marketCap":2238630612},{"date":"2024-01-26","current":-14.843603,"twenty":-15.020547,"median":-12.776843,"eighty":-11.648787,"marketCap":2305820071},{"date":"2024-02-02","current":-14.991056,"twenty":-15.264335,"median":-13.370218,"eighty":-11.652719,"marketCap":2328725569},{"date":"2024-02-09","current":-17.1537,"twenty":-15.346909,"median":-13.691957,"eighty":-11.671529,"marketCap":2664672864},{"date":"2024-02-16","current":-18.490607,"twenty":-15.539581,"median":-13.783396,"eighty":-11.691031,"marketCap":2872349373},{"date":"2024-02-23","current":-18.500437,"twenty":-15.932789,"median":-13.819852,"eighty":-11.69454,"marketCap":2873876407},{"date":"2024-03-01","current":-17.330643,"twenty":-16.668088,"median":-13.939224,"eighty":-11.709735,"marketCap":2692159461},{"date":"2024-03-08","current":-12.297819,"twenty":-16.990518,"median":-13.97363,"eighty":-11.717599,"marketCap":2901363004},{"date":"2024-03-15","current":-10.189453,"twenty":-16.81554,"median":-13.826354,"eighty":-11.69454,"marketCap":2403946708},{"date":"2024-03-22","current":-9.414974,"twenty":-16.668088,"median":-13.783396,"eighty":-11.650753,"marketCap":2221227691},{"date":"2024-03-28","current":-8.492333,"twenty":-16.613039,"median":-13.722203,"eighty":-11.579976,"marketCap":2003553733},{"date":"2024-04-05","current":-9.246609,"twenty":-16.364935,"median":-13.534996,"eighty":-11.491504,"marketCap":2181506166},{"date":"2024-04-12","current":-9.435178,"twenty":-16.111698,"median":-12.865966,"eighty":-11.216259,"marketCap":2225994275},{"date":"2024-04-19","current":-7.105005,"twenty":-15.954415,"median":-12.753675,"eighty":-10.606446,"marketCap":1676248365},{"date":"2024-04-26","current":-6.123304,"twenty":-15.846283,"median":-12.728927,"eighty":-10.162515,"marketCap":1444640411},{"date":"2024-05-03","current":-6.231441,"twenty":-15.669339,"median":-12.297819,"eighty":-9.792112,"marketCap":1470152824},{"date":"2024-05-10","current":-6.135514,"twenty":-15.610358,"median":-12.155389,"eighty":-9.435178,"marketCap":1558549450},{"date":"2024-05-17","current":-6.047595,"twenty":-15.433415,"median":-12.120637,"eighty":-9.273547,"marketCap":1536216091},{"date":"2024-05-24","current":-5.846636,"twenty":-15.423584,"median":-11.91675,"eighty":-8.957021,"marketCap":1485168412},{"date":"2024-05-31","current":-6.085275,"twenty":-15.399992,"median":-11.884712,"eighty":-8.469435,"marketCap":1545787530},{"date":"2024-06-07","current":-6.235993,"twenty":-15.362637,"median":-11.806071,"eighty":-7.09423,"marketCap":1584073290},{"date":"2024-06-14","current":-6.248553,"twenty":-15.342977,"median":-11.75692,"eighty":-6.904314,"marketCap":1587263770},{"date":"2024-06-21","current":-5.557759,"twenty":-15.335113,"median":-11.717599,"eighty":-6.419582,"marketCap":1411787373},{"date":"2024-06-28","current":-5.777557,"twenty":-15.335113,"median":-11.707769,"eighty":-6.279953,"marketCap":1467620772},{"date":"2024-07-05","current":-6.129234,"twenty":-15.228947,"median":-11.690896,"eighty":-6.264891,"marketCap":1556954210},{"date":"2024-07-12","current":-7.253346,"twenty":-15.12278,"median":-11.653703,"eighty":-6.277441,"marketCap":1842502165},{"date":"2024-07-15","current":-6.939348,"twenty":-15.110984,"median":-11.648787,"eighty":-6.278697,"marketCap":1762740166},{"date":"2024-08-02","current":-7.931581,"twenty":-15.099188,"median":-11.648787,"eighty":-6.279953,"marketCap":2014788082},{"date":"2024-08-09","current":-6.56038,"twenty":-15.040207,"median":-11.579976,"eighty":-6.279953,"marketCap":1798711865},{"date":"2024-08-16","current":-6.881395,"twenty":-14.991056,"median":-11.493728,"eighty":-6.279953,"marketCap":1886727125},{"date":"2024-08-23","current":-6.712133,"twenty":-14.991056,"median":-11.447336,"eighty":-6.393648,"marketCap":1840319079},{"date":"2024-08-30","current":-6.54287,"twenty":-14.922244,"median":-11.299816,"eighty":-6.436952,"marketCap":1793911032},{"date":"2024-09-06","current":-6.297731,"twenty":-14.859331,"median":-10.957407,"eighty":-6.374465,"marketCap":1726699379},{"date":"2024-09-13","current":-6.904742,"twenty":-14.68632,"median":-10.606446,"eighty":-6.374465,"marketCap":1893128235},{"date":"2024-09-20","current":-7.430039,"twenty":-14.481851,"median":-10.304733,"eighty":-6.410301,"marketCap":2037153206},{"date":"2024-09-27","current":-7.634321,"twenty":-14.416972,"median":-9.973946,"eighty":-6.432454,"marketCap":2093162917},{"date":"2024-10-04","current":-7.905725,"twenty":-14.387481,"median":-9.835887,"eighty":-6.454177,"marketCap":2167575819},{"date":"2024-10-11","current":-8.988421,"twenty":-14.365855,"median":-9.536197,"eighty":-6.471402,"marketCap":2464427288},{"date":"2024-10-18","current":-9.898936,"twenty":-14.275648,"median":-9.492422,"eighty":-6.494727,"marketCap":2714070572},{"date":"2024-10-25","current":-7.587628,"twenty":-14.23812,"median":-9.435178,"eighty":-6.5109,"marketCap":2080360698},{"date":"2024-10-31","current":-7.126534,"twenty":-14.186945,"median":-9.414974,"eighty":-6.517189,"marketCap":1953938778},{"date":"2024-11-08","current":-7.599301,"twenty":-14.11026,"median":-9.329429,"eighty":-6.519524,"marketCap":2083561252},{"date":"2024-11-15","current":-6.430581,"twenty":-14.036864,"median":-9.246609,"eighty":-6.508113,"marketCap":1888648838},{"date":"2024-11-22","current":-5.330396,"twenty":-14.008036,"median":-9.078889,"eighty":-6.434404,"marketCap":1565526710},{"date":"2024-11-29","current":-5.467919,"twenty":-13.980511,"median":-8.972721,"eighty":-6.336098,"marketCap":1605916976},{"date":"2024-12-06","current":-5.313893,"twenty":-13.902792,"median":-8.614876,"eighty":-6.276185,"marketCap":1560679878},{"date":"2024-12-13","current":-5.819979,"twenty":-13.839429,"median":-8.495238,"eighty":-6.248553,"marketCap":1709316057},{"date":"2024-12-20","current":-5.775971,"twenty":-13.821153,"median":-8.377845,"eighty":-6.222869,"marketCap":1696391172},{"date":"2024-12-27","current":-6.238049,"twenty":-13.812967,"median":-8.200475,"eighty":-6.175381,"marketCap":1832102465},{"date":"2025-01-03","current":-1.083682,"twenty":-13.811432,"median":-8.147945,"eighty":-6.157876,"marketCap":318275296},{"date":"2025-01-10","current":-1.303719,"twenty":-13.766574,"median":-7.931581,"eighty":-6.140538,"marketCap":382899721},{"date":"2025-01-17","current":-1.193701,"twenty":-13.753032,"median":-7.891133,"eighty":-6.119668,"marketCap":350587508},{"date":"2025-01-24","current":-1.1882,"twenty":-13.716154,"median":-7.812392,"eighty":-6.085275,"marketCap":348971898},{"date":"2025-01-31","current":-1.056178,"twenty":-13.615504,"median":-7.634321,"eighty":-6.067691,"marketCap":310197242},{"date":"2025-02-07","current":-1.07268,"twenty":-13.546812,"median":-7.564281,"eighty":-5.978405,"marketCap":315044074},{"date":"2025-02-14","current":-0.929656,"twenty":-13.337262,"median":-7.53602,"eighty":-5.966304,"marketCap":273038198},{"date":"2025-02-21","current":-0.940658,"twenty":-13.1053,"median":-7.470895,"eighty":-5.920328,"marketCap":276269419},{"date":"2025-02-28","current":-0.852643,"twenty":-12.883791,"median":-7.424202,"eighty":-5.847483,"marketCap":250419649},{"date":"2025-03-07","current":-1.009931,"twenty":-12.773914,"median":-7.253346,"eighty":-5.800175,"marketCap":246207962},{"date":"2025-03-14","current":-0.930199,"twenty":-12.763183,"median":-7.144044,"eighty":-5.763741,"marketCap":226770492},{"date":"2025-03-21","current":-0.770737,"twenty":-12.752113,"median":-7.105005,"eighty":-5.687956,"marketCap":187895550},{"date":"2025-03-28","current":-0.730871,"twenty":-12.743752,"median":-7.036301,"eighty":-5.574632,"marketCap":178176815},{"date":"2025-04-04","current":-0.564099,"twenty":-12.730087,"median":-6.998128,"eighty":-5.417311,"marketCap":137520105},{"date":"2025-04-11","current":-0.476129,"twenty":-12.580434,"median":-6.945391,"eighty":-5.374404,"marketCap":116074096},{"date":"2025-04-17","current":-0.41859,"twenty":-12.352677,"median":-6.926527,"eighty":-5.321594,"marketCap":102046721},{"date":"2025-04-25","current":-0.497989,"twenty":-12.291873,"median":-6.904742,"eighty":-1.375231,"marketCap":121403202},{"date":"2025-05-02","current":-0.511809,"twenty":-12.245663,"median":-6.881395,"eighty":-1.223405,"marketCap":124772347},{"date":"2025-05-09","current":-0.423699,"twenty":-12.15573,"median":-6.846375,"eighty":-1.1893,"marketCap":103292222},{"date":"2025-05-16","current":-0.417316,"twenty":-12.148314,"median":-6.834702,"eighty":-1.12879,"marketCap":107691766},{"date":"2025-05-23","current":-0.449909,"twenty":-12.121955,"median":-6.75723,"eighty":-1.07488,"marketCap":116102658},{"date":"2025-05-30","current":-0.450473,"twenty":-12.120637,"median":-6.747152,"eighty":-1.061679,"marketCap":116248231},{"date":"2025-06-06","current":-0.507762,"twenty":-12.041995,"median":-6.685868,"eighty":-1.033834,"marketCap":131031991},{"date":"2025-06-13","current":-0.562731,"twenty":-11.924033,"median":-6.5954,"eighty":-0.989998,"marketCap":145217284},{"date":"2025-06-20","current":-0.488895,"twenty":-11.91238,"median":-6.57789,"eighty":-0.951354,"marketCap":126163379},{"date":"2025-06-26","current":-0.506383,"twenty":-11.900512,"median":-6.56038,"eighty":-0.940658,"marketCap":130676146}],"updateTime":1751088783951}}}